PolyPid Ltd. (PYPD) Social Stream
PolyPid Ltd (PYPD) Price Targets From Analysts
Use the tables below to see what analysts covering PolyPid Ltd think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 52 weeks, PYPD's average price target has gone down $5.47.
PYPD reports an average of 201.75% for its upside potential over the past 45 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PYPD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PYPD's average broker recommendation rating improved by 0.5 over the prior 153 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PYPD as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, PolyPid Ltd's upside potential (average analyst target price relative to current price) is higher than 181.16% of them.
- PYPD has a greater number of analysts covering the stock than 22.3% of all US stocks.
- PYPD has a lower variance in analysts' estimates than -55.83% of Medical Equipment stocks.
- In the context of stocks in the micro market cap category, PolyPid Ltd's average analyst price target is higher than 149% of them.
Is PYPD a Buy, Hold or Sell? See the POWR Ratings now!